Non-skin Solid Tumors as a Cause of Morbidity and Mortality After Liver Transplantation

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2433-2434

  Fraile, P ^a   Garcia Cosmes P ^a   Martin P ^a   Garcia Bernalt V ^a   Tabernero, J M ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; SOLID TUMOR; STOMACH CANCER; SURGICAL MORTALITY; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; AZATHIOPRINE; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LIVER TRANSPLANTATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORBIDITY; MUROMONAB-CD3; NEOPLASMS; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; SKIN DISEASES; SPAIN; SURVIVAL RATE; TACROLIMUS; YOUNG ADULT;

EID: 68949200874     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.022     Document Type: Article

References (4)

1. Buell J.F., Gross T.G., and Woodle E.S. Malignancy after transplantation. Transplantation 15 (2005) 254
2. Kapoor A. Malignancy in kidney transplant recipients. Drugs 68 suppl 1 (2008) 11
3. Morath C., Mueller M., Goldschmidt H., et al. Malignancy in renal transplantation. J Am Soc Nephrol 15 (2004) 1582
4. Wimmer C.D., Rentsch M., Crispin A., et al. The janus face of immunosuppression: de novo malignancy after renal transplantation; the experience of the Transplantation Center Munich. Kidney Int 71 (2007) 1271